bispecific biopharmaceuticals (Ossianix/Lundbeck)
N/A
Report date: 2025/03/14 20:00:48
NME
Base Information
Drug Namebispecific biopharmaceuticals (Ossianix/Lundbeck)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOssianix Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesOssianix IncH. Lundbeck A/S
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A